ATEF SHAIKH: Open Payments
NPI 1578908604 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,641 in 66 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $860 · 2025 $1,641
Food & beverage: $1,641
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $273 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $200 |
| Teva Pharmaceuticals USA, Inc. | 7 | $186 |
| Neurocrine BioSciences, Inc. | 5 | $153 |
| Vanda Pharmaceuticals Inc. | 5 | $140 |
| Alkermes, Inc. | 6 | $126 |
| Axsome Therapeutics, Inc. | 3 | $97 |
| Biogen, Inc. | 3 | $88 |
| ABBVIE INC. | 5 | $85 |
| Collegium Pharmaceutical, Inc. | 3 | $68 |
Products named: COBENFY, CAPLYTA, AUSTEDO XR, INGREZZA, HETLIOZ, ARISTADA, REXULTI, Auvelity.
Industry payments across CA — which companies pay providers there.
